Henrik Schmidt
@henrikschm
Business Development Manager @ Myllia Biotechnology
It's about one month to go until BIO US 2025 in Boston! Are you attending as well? If so, please reach out to our CSO @burckstummer and our BD Manager @henrikschm who will be attending #BIO2025 from June 16-19, 2025. Contact us via: 📩 [email protected] 📰 myllia.com
Looking forward to representing @MylliaBio at the #SwissBiotechDay 2025 in Basel and discussing drug target ID/validation powered by single-cell CRISPR screens in primary human cells! 🎯 Explore Myllia's platform: myllia.com 📩 Contact: [email protected]
We will be at #AACR25 in Chicago, USA Poster presentation: "A compressed genome-wide CROP-Seq screen to dissect the polarization of THP-1-derived macrophages" 🎯 When: Sunday, April 27 from 2.00 - 5.00 PM EST 🎯 Poster: LB043, Section 52 myllia.com #CRISPR
🚀 At @MylliaBio, we're advancing scRNA-Seq in primary human cells with our targeted sequencing (TA-Seq) platform! Key insights: • TA-Seq uses 10K reads/cell vs. 50K reads/cell for WTA • Low-abundance mRNAs are detected more effectively with TA-Seq myllia.com
A team at @MylliaBio contributed one of the largest single-cell CRISPR perturbation screens published today: nature.com/articles/s4155… The lab of Wei Li developed the perturbation-response score (PS) allowing the quantification of diverse perturbation responses in single cells!
🧬 At @MylliaBio, we're pushing the boundaries of scCRISPR screens in primary human T cells. For example, we focus on scalable CROP-Seq screens to uncover key mediators of T helper cell differentiation, particularly Th2 cells! myllia.com #CRISPR #scRNASeq #TCells
📢 One month to go! @MylliaBio will be at #BIOEuropeSpring 2025 in Milan, Italy! Would you like to get in touch? Meet our BD Manager @henrikschm on site to explore #CRISPR-based #functional #genomics screens in primary human cells! Learn more here: myllia.com
🔬 At @MylliaBio, we're revolutionizing target discovery with CROP-Seq in primary human T cells: - Custom assay development - SLICE protocol for functional screening - Integration of CITE-Seq & scRNA-Seq Ready to elevate your research? Contact us via: myllia.com
Can #AI predict #CRISPR perturbation outcomes? @MylliaBio's CROP-Seq dataset provides a critical resource for AI-driven #Foundation #Models of the Human Cell: CROP-Seq training datasets for AI-based foundation models of human cell biology — Myllia
Did you know @MylliaBio has a #YouTube channel? If you like, check out some of the edutainment videos we've created to showcase our single-cell #CRISPR #screening platform! Become "famyllia" with CROP-Seq (Perturb-Seq): youtu.be/8TS794MDHwg?si…
At @MylliaBio, we use single-cell #CRISPR screens for target discovery in challenging cell models, e.g., primary T cells. Watch the latest #interview with @burckstummer at @ELRIG_UK Drug Discovery 2024 and reach out to discuss your next CRISPR project! youtu.be/9Po9Tlvrrgk?si…
I am representing @MylliaBio at Single-Cell Genomics 2024 in Paris, France - thanks to @InstitutImagine for hosting the event! Reach out to discuss your next #CRISPR #screening and #functional #genomics projects for drug target discovery in single cells! myllia.com
We're #hiring a Lab Associate/Lab Scientist at Myllia Biotechnology in Vienna, Austria! Check out the job description online, if you're fascinated by CRISPR, functional genomics and cell biology: myllia.com/careers/ #TeamMyllia #job
Join us at #BIOEurope 2024 in Stockholm! We look forward to discussing new CRISPR screening #partnerships for target ID/validation and drug discovery. myllia.com #TeamMyllia #CRISPR #Screening #FGX
🔊 Job alert! - We are #hiring a Lab Associate/Lab Scientist at @MylliaBio in Vienna, Austria! If you are fascinated about functional genomics and primary immune cell biology, please send us your application via [email protected] - myllia.com/careers/ #TeamMyllia #CRISPR
Recently, @MylliaBio gathered next to the @viennabiocenter for a new 2024 group picture - it's great to have you all on board to tackle exciting #CRISPR #screening projects with biotech and pharma clients across the globe! 🚀#TeamMyllia #Vienna ➡️myllia.com
🚀 Exciting times ahead! @MylliaBio is headed to #BIO2024 in San Diego! Looking forward to connecting with top #biotech and #pharma companies to drive innovation in target discovery. #crispr #research
Super excited to attend the #BIO2024 in sunny San Diego next month! Reach out if you'd like to meet in-person to discuss #CRISPR screens at scale for target ID and validation!
We're gearing up for #BIO2024 in San Diego! Looking forward to connecting with potential collaborators at this year's #biopharma #partnering event - stay tuned for updates about #functional #genomics and #genetic #screening for target ID in primary cells! myllia.com
Have you registered for BIO 2024? I'll be representing @MylliaBio at this year's BIO International Convention in San Diego, CA. Looking forward to connect and collaborate June 3-6, 2024. #BIO2024 share.bio.org/s/spmq7tpKhi64…
It's been great fun joining #CRISPR24 at @sangerinstitute and @HinxtonHall to showcase how large-scale perturbation screens advance biomedical research! Interested in single-cell CRISPR screens for target ID? Check out the website: myllia.com
